7th Leducq Network Virtual Meeting on Dec/12/2022
Start @ 09:30 Portland, 11:30 Nashville, 12:30 Baltimore, 18.30 Aarhus/Lausanne, 03:30 Brisbane (Tuesday morning, Stowasser group not expected to attend until 6am local)
Time: Dec 12, 2022 11:30 AM Central Time (US and Canada)
Join Zoom Meeting https://zoom.us/j/95509361490
NOTE. TIME ALLOCATION INCLUDES Q&A
12:30-13:25 Baltimore time (18.30 – 19.25 Europe). Welling group (Johns Hopkins)
12:30-12:50 Rick Grimm, Ph.D. Finding the Sweet Spot, Updates
12:50-13:10 Hyun Jun Jung, Ph.D. Updates on DCT remodeling, Finding TF treasures
13:10-13:25 Paul Welling, MD; Summary and plans
Open discussion and break
13:30-14:10 Baltimore time (19.30 – 20.10 Europe). Delpire group (Vanderbilt)
13:30 – 13:50 Eric Delpire, Ph.D: Revisiting the regulation of NCC
13:50 – 14:10 Mohammed Ferdaus, Ph.D. KCC3a and K+ loss in alkalemia
Open discussion and break
14:15-14:45 Baltimore time (20.15 – 20.45 Europe): Fenton group (Aarhus)
14:15-14:30 Søren Poulsen, Ph.D. Glucagon activates NCC in a glucagon receptor-dependent manner
14:30-14:45 Robert Fenton, Ph.D. Summary and plans
Open discussion and break
15:00-15:45 Baltimore time (21.00 – 21.45 Europe). Staub group (Lausanne)
15:00 – 15:20 Olivier Staub, Ph.D. The role of mineralocorticoid receptor in the potassium switch: effect on NCC regulation
15:20-15:40 Alessandro Marazza, PhD. Dissecting the role of PIM kinases in the kidney
Open discussion and break
15:45-16:30 Baltimore time (21.45 – 22.30 Europe). Ellison group (OHSU)
15:00-15:05 Ellison: Introduction
15:05-15:30 Xiao-Tong Su, Ph.D. Post-doctoral fellow,
Four weeks of dietary potassium restriction causes distal convoluted tubule
16:30-17:15 Baltimore time (22.30 – 23.15 Europe, 07.00 – 08.30 Brisbane). Stowasser group
16:30-16:50 Aihua (Nicole) Wu, Ph.D Clinical studies on potassium in hypertension: progress since Boston
16:50-17:10 Michael Stowasser MD. Clinical studies on potassium in hypertension: proposed studies for 2023
3rd Virtual Leducq Association talked Series on Thursday Sep/22
Investigating the A-Kinase anchoring protein 2 (AKAP2) role in the kidney and its potential involvement in acid-base homeostasis
Houwayda Belaid (University of Lausanne)
A core regulatory axis of DCT for structural remodeling in response to furosemide
Hyun Jun Jung, PhD (Johns Hopkins)
2nd Virtual Leducq Association meeting on Thursday Apr/22
Update on chronic K+ effects on Blood Pressure
Robert Little, PhD (Aarhus University)
Utilizing Chemogenetic Tools to Study Distal Convoluted Tubule Function
Tanner Bradford (Oregon Health Science University)
1st Virtual Leducq Association talked Series on Thursday March/17
The Aldosterone Sweet Spot
Rick Grimm, PhD (Johns Hopkins University, Baltimore)
A role for KCC3a in Pendrin regulation and Cl– homeostasis?
Mohammed Ferdaus, PhD (Vanderbilt University, Nashville)
Sixth Leducq Network Talk on Thursday Sep/02
NCC and human hypertension
Michael Stowasser, MD
Fifth Leducq Network Talk on Thursday Jun/03
Aldosterone-dependent signaling networks controlling potassium homeostasis
Olivier Staub, PhD
Fourth Leducq Network Talk on Thursday May/06
The pseudokinase KS-WNK1: activator, inhibitor, or both
David Ellison, MD
Questions?
Please contact info@potassium-bloodpressure.org